Trulieve Cannabis Corp(TRLV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 7:20 PM ET (Korea 10/28 08:20)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -2.46 | Insider Own | 15.55% | Shs Outstand | 170.0M | Perf Week | -1.11% |
| Market Cap | 2.05B | Forward P/E | 18.56 | EPS next Y | 131.56% | Insider Trans | -5.37% | Shs Float | 162.6M | Perf Month | -13.53% |
| Enterprise Value | 2.30B | PEG | - | EPS next Q | 0.09 | Inst Own | 17.78% | Short Float | 4.46% | Perf Quarter | 32.38% |
| Income | -0.47B | P/S | 1.8 | EPS this Y | -198.69% | Inst Trans | 26.42% | Short Ratio | 4.32 | Perf Half Y | 5.85% |
| Sales | 1.14B | P/B | 2.67 | EPS next 5Y | - | ROA | -18.72% | Short Interest | 7.26M | Perf YTD | 22.78% |
| Book/sh | 3.99 | P/C | 6.31 | EPS past 3/5Y | 22.54% - | ROE | -46.96% | 52W High | -19.65% ($13.28) | Perf Year | 45.57% |
| Cash/sh | 1.69 | P/FCF | 10.66 | Sales past 3/5Y | -1.02% 17.76% | ROIC | -35.9% | 52W Low | 131.15% ($4.62) | Perf 3Y | 177.14% |
| Dividend Est. | - | EV/EBITDA | 7.06 | EPS Y/Y TTM | -177.39% | Gross Margin | 49.43% | Volatility(W/M) | 6.71% 6.11% | Perf 5Y | -57.41% |
| Dividend TTM | - | EV/Sales | 2.02 | Sales Y/Y TTM | -3.9% | Oper. Margin | 13.75% | ATR (14) | 0.68 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.98 | EPS Q/Q | -2821.78% | Profit Margin | -41.55% | RSI (14) | 48.43 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.94 | Sales Q/Q | -10.31% | SMA20 | 1% ($10.56) | Beta | 1.9 | Target Price | $18.18 |
| Payout | - | Debt/Eq | 0.75 | Earnings | 2026/11/5 | SMA50 | -4.44% ($11.17) | Rel Volume | 0.52 | Prev Close | $10.82 |
| Employees | 5000 | LT Debt/Eq | 0.72 | EPS/Sales Surpr. | -2544.96% 0.91% | SMA200 | 21.34% ($8.79) | Avg Volume(3M) | 1.68M | Price | $10.67 |
| IPO | 2018/9/27 | Option/Short | Yes/Yes | Trades | 6643 | Volume | 868,001 | Change | -1.39% |
🌿 A large-scale cannabis company that operates integrated cultivation, processing, and distribution across major U.S. regions, including Florida. Through its vertically integrated business model and extensive proprietary retail distribution network, it is leading the medical and recreational cannabis markets.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
Traded less than usual. That is 52% of its average volume.
Next earnings report: November 5
8 days to go.
TRLV keeps an operating profit but posts a net loss
Of every $100 in sales, $13.75 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -198.7% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $180. Peers typically go for $225.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -57.4%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 17.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
YOLO AdvisorShares Pure Cannabis ETF 0.13% 
MSOS AdvisorShares Pure US Cannabis ETF 0.10% It ranks #25 of 83 in the industry
Based on market cap of $2B.
FAQ
What kind of company is TRLV?
TRLV belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of TRLV?
The market cap of TRLV is approximately $2.1B, ranking 2,039 within its sector.
What is the 52-week high and low for TRLV?
TRLV has recorded a 52-week high of $13.28 and a low of $4.62.
